Figure 3From: A phase 1 trial of nebulised heparin in acute lung injuryChanges in alveolar dead space fraction with nebulised heparin dosage. Percentage change from baseline in the alveolar dead space fraction (ADSF) (mean ± standard deviation).Back to article page